Subcutaneous implantable cardioverter-defibrillator therapy in Poland: Results of the Polish S-ICD Registry.
Kempa M, Budrejko S, Tajstra M, Syska P, Lewandowski M, Fabiszak T, Michalak M, Stanek A, Nowak K, Mitkowski P, Kaczmarek K, Orski Z, Janowski M, Szafarz P, Filipecki A, Sokal A, Szołkiewicz M, Jagielski D, Przybylski A.
Kardiol Pol. 2023;81(5):455-462. doi: 10.33963/KP.a2023.0046. Epub 2023 Mar 5.
The prevalence of implantable cardioverter-defibrillator (ICD) and heart failure patients eligible for remote monitoring in Germany.
Schwab JO, Gricar B, Hauser T.
BMC Cardiovasc Disord. 2024 Oct 17;24(1):572. doi: 10.1186/s12872-024-04245-8.
Periprocedural outcomes from the postmarket study of the extravascular implantable cardioverter-defibrillator: Preliminary Enlighten study results and meta-analysis.
Crozier I, Murgatroyd F, Amin A, Clementy N, Duncker D, Kotschet E, Wiggenhorn C, Boersma LVA.
Heart Rhythm. 2026 Jan;23(1):180-185. doi: 10.1016/j.hrthm.2025.02.012. Epub 2025 Apr 2.
Implantation of Implantable Cardioverter Defibrillators in Kazakhstan.
Begisbayev T, Kosherbayeva L, Akhmetov V, Khvan D, Brimzhanova M.
Glob Heart. 2022 May 10;17(1):30. doi: 10.5334/gh.1119. eCollection 2022.
Feasibility of subcutaneous implantable cardioverter-defibrillator implantation with opioid sparing truncal plane blocks and deep sedation.
Miller MA, Garg J, Salter B, Brouwer TF, Mittnacht AJ, Montgomery ML, Honikman R, Arkonac DE, Choudry S, Dukkipati SR, Reddy VY, Weiner MM.
J Cardiovasc Electrophysiol. 2019 Jan;30(1):141-148. doi: 10.1111/jce.13750. Epub 2018 Oct 22.
The timing of implantable cardioverter-defibrillator implantation in patients with heart failure.
Al-Majed NS, Ezekowitz JA.
Curr Cardiol Rep. 2012 Jun;14(3):299-307. doi: 10.1007/s11886-012-0262-1.
Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes.
Jędrzejczyk-Patej E, Mazurek M, Kotalczyk A, Kowalska W, Konieczny-Kozielska A, Kozielski J, Podolecki T, Szulik M, Sokal A, Kowalski O, Kalarus Z, Średniawa B, Lenarczyk R.
Europace. 2021 Jan 27;23(1):113-122. doi: 10.1093/europace/euaa339.
Performance of an implantable cardioverter-defibrillator lead family.
Klampfleitner S, Mundel M, Schinke K, Neuberger HR.
J Cardiovasc Electrophysiol. 2023 Mar;34(3):700-709. doi: 10.1111/jce.15804. Epub 2023 Jan 22.
The implantable cardioverter-defibrillator: An update.
Miller JD, Yousuf O, Berger RD.
Trends Cardiovasc Med. 2015 Oct;25(7):606-11. doi: 10.1016/j.tcm.2015.01.015. Epub 2015 Feb 7.
[History of the implantable cardioverter-defibrillator in Germany].
Block M, Klein HU.
Herzschrittmacherther Elektrophysiol. 2024 Mar;35(Suppl 1):55-67. doi: 10.1007/s00399-024-01001-5. Epub 2024 Feb 29.
